GATA binding protein 3 overexpression and suppression significantly contribute to the regulation of allergic skin inflammation

International Journal of Molecular Medicine

Volumn 28, Issue 2, 2011, Pages 171-179

  Bae, Chang Jun ^a,b   Lee, Jae Won ^a   Shim, Sun Bo ^a   Jee, Seung Wan ^a   Lee, Su Hae ^a   Woo, Jong Min ^a   Lee, Chang Kyu ^b   Hwang, Dae Youn ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Seoul National University   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

Allergic disease; Human GATA binding protein 3; Skin inflammation; Transgenic mice

Indexed keywords

COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PHTHALIC ANHYDRIDE; RANTES; TRANSCRIPTION FACTOR GATA 3; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; DOWN REGULATION; EAR DISEASE; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; FERTILIZATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; LYMPH NODE; MALE; MICROINJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLERGY; TH1 CELL; TH2 CELL; THYMUS; WILD TYPE;

ANIMALS; CYTOKINES; EAR; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN G; INFLAMMATION; JURKAT CELLS; LYMPH NODES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; SKIN; THYMUS GLAND;

EID: 79958153328     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.685     Document Type: Article

References (33)

1. Larche M, Robinson DS and Kay AB: The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111: 450-464, 2003.
2. Cousins DJ, McDonald J and Lee TH: Therapeutic approaches for control of transcription factors in allergic disease. J Allergy Clin Immunol 121: 803-811, 2008.
3. Zheng W and Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596, 1997. (Pubitemid 27511769)
4. Abbas AK, Murphy KM and Sher A: Functional diversity of helper T lymphocytes. Nature 383: 787-793, 1996.
5. 4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16: 34-38, 1995.
6. Farrar JD, Asnagli H and Murphy KM: T helper subset development: roles of instruction, selection, and transcription. J Clin Invest 109: 431-435, 2002. (Pubitemid 34171771)
7. Ansel KM, Djuretic I, Tanasa B and Rao A: Regulation of Th2 differentiation and I14 locus accessibility. Annu Rev Immunol 24: 607-656, 2006.
8. Lee GR, Fields PE and Flavell RA: Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14: 447-459, 2001. (Pubitemid 32441597)
9. Pai SY, Truitt ML and Ho IC: GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci USA 101: 1993-1998, 2004.
10. Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, Wang Q, Killen N, Urban JF Jr, Guo L and Paul WE: Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol 5: 1157-1165, 2004. (Pubitemid 39549630)
11. Nakamura Y, Christodoulopoulos P, Cameron L, Wright E, Lavigne F, Toda M, Muro S, Ray A, Eidelman DH, Minshall E and Hamid Q: Upregulation of the transcription factor GATA-3 in upper airway mucosa after in vivo and in vitro allergen challenge. J Allergy Clin Immunol 105: 1146-1152, 2000. (Pubitemid 30418794)
12. Nakamura Y, Ghaffar O, Olivenstein R, Taha RA, Soussi-Gounni A, Zhang DH, Ray A and Hamid Q: Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 103: 215-222, 1999. (Pubitemid 29095824)
13. Kiwamoto T, Ishii Y, Morishima Y, Yoh K, Maeda A, Ishizaki K, Iizuka T, Hegab AE, Matsuno Y, Homma S, Nomura A, Sakamoto T, Takahashi S and Sekizawa K: Transcription factors T-bet and GATA-3 regulate development of airway remodeling. Am J Respir Crit Care Med 174: 142-151, 2006. (Pubitemid 44015387)
14. Yamashita N, Tashimo H, Ishida H, Matsuo Y, Tamauchi H, Terashima M, Yoshiwara I, Habu S and Ohta K: Involvement of GATA-3-dependent Th2 lymphocyte activation in airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol 290: 1045-1051, 2006.
15. Hwang DY, Seo S, Kim Y, Kim C, Shim S, Jee S, Lee S, Sin J, Cho J, Kang B, Jang I and Cho J: Significant change in insulin production, glucose tolerance and ER stress signaling in transgenic mice coexpressing insulin-siRNA and human IDE. Int J Mol Med 19: 65-73, 2007.
16. Ban M and Hettich D: Effect of Th2 cytokine antagonist treatments on chemical-induced allergic response in mice. J Appl Toxicol 25: 239-247, 2005. (Pubitemid 40806346)
17. Dearman RJ and Kimber I: Divergent immune responses to respiratory and contact chemical allergens: antibody elicited by phthalic anhydride and oxazolone. Clin Exp Allergy 22: 241-250, 1992.
18. De Vry CG, Valdez M, Lazarov M, Muhr E, Buelow R, Fong T and Iyer S: Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol esterinduced dermatitis model. J Invest Dermatol 125: 473-481, 2005.
19. Kang JS, Youm JK, Jeong SK, Park BD, Yoon WK, Han MH, Lee H, Han SB, Lee K, Park SK, Lee SH, Yang KH, Moon EY and Kim HM: Topical application of a novel ceramide derivative, K6PC-9, inhibits dust mite extract-induced atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol 7: 1589-1597, 2007. (Pubitemid 350046422)
20. Azoulay E, Attalah H, Yang K, Jouault H, Schlemmer B, Brun-Buisson C, Brochard L, Harf A and Delclaux C: Exacerbation by granulocyte colony-stimulating factor of prior acute lung injury: implication of neutrophils. Crit Care Med 30: 2115-2122, 2002.
21. Gao XK, Nakamura N, Fuseda K, Tanaka H, Inagaki N and Nagai H: Establishment of allergic dermatitis in NC/Nga mice as a model for severe atopic dermatitis. Biol Pharm Bull 27: 1376-1381, 2004. (Pubitemid 41701678)
22. Yoh K, Shibuya K, Morito N, Nakano T, Ishizaki K, Shimohata H, Nose M, Izi S, Shibuya A, Koyama A, Engel JD, Yamamoto M and Takahashi S: Transgenic overexpression of GATA-3 in T lymphocytes improves autoimmune glomerulonephritis in mice with a BXSB/MpJ-Yaa genetic background. J Am Soc Nephrol 14: 2494-2502, 2003. (Pubitemid 37169335)
23. Dearman RJ, Skinner RA, Humphreys NE and Kimber I: Methods for the identification of chemical respiratory allergens in rodents: comparisons of cytokine profiling with induced changes in serum IgE. J Appl Toxicol 23: 199-207, 2003. (Pubitemid 36950287)
24. Dearman RJ and Kimber I: Cytokine fingerprinting and hazard assessment of chemical respiratory allergy. J Appl Toxicol 21: 153-163, 2001. (Pubitemid 32288363)
25. Lee JS, Lee CM, Jeong YI, Jung ID, Kim BH, Seong EY, Kim JI, Choi IW, Chung HY and Park YM: D-pinitol regulates Th1/Th2 balance via suppressing Th2 immune response in ovalbumin-induced asthma. FEBS Lett 581: 57-64, 2007. (Pubitemid 44960280)
26. Dubois GR and Bruijnzeel PL: IL-4-induced migration of eosinophils in allergic inflammation. Ann NY Acad Sci 725: 268-273, 1994. (Pubitemid 24222055)
27. Davis A, Christiansen M, Horowitz JF, Klein S, Hellerstein MK and Ostlund RE Jr: Effect of pinitol treatment on insulin action in subjects with insulin resistance. Diabetes Care 23: 1000-1005, 2000. (Pubitemid 30480031)
28. Gober MD and Gaspari AA: Allergic contact dermatitis. Curr Dir Autoimmun 10: 1-26, 2008.
29. Gabay C: Interleukin-6 and chronic inflammation. Arthritis Res Ther 8 (Suppl 2): S3, 2006.
30. Detma M, Brown LF, Schön MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP and Jain RK: Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111: 1-6, 1998. (Pubitemid 28309201)
31. Dvorak HF, Brown LF, Detmar M and Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
32. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT and De Bruijn EA: Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580, 2004. (Pubitemid 39658463)
33. Hvid H, Teige I, Kvist PH, Svensson L and Kemp K: TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis. Int Immunol 20: 1097-1106, 2008.